Out-of-hospital cardiac arrest (OHCA) in people experiencing a heart attack is a time-dependent medical emergency requiring ...
In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.
In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.
SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.
Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...
Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.
The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...
After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...
Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...
A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...
11d
HealthDay on MSNSotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk FactorsFor patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results